Category: Guest content

Biotechnology Management Papers, 2010

These papers are from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: If You Build It, Will They Come? Derek Francis Profitability […]


Profitability and Orphans: The Role of Price and Incentives in Four Different Markets

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Profitability and Orphans: The Role of Price […]


If You Build It, Will They Come?

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. If You Build It, Will They Come? […]


Patent Analysis: A Tool for Making Strategic Business Decisions

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Patent Analysis: A Tool for Making Strategic […]


Guest post: Healthcare Reform Bill Presents Significant Opportunity for Life Science Companies Engaged in Innovative Research

This is a guest post from William H. Kitchens, partner at the Atlanta law firm Arnall Golden Gregory LLP. Do you have a response to Kitchens’ post? Respond in the comments section below. Buried in the recently enacted Patient Protection and Affordable Care Act of 2010 is a significant benefit for small- and mid-sized biotech, […]


Top 4 Healthcare Predictions for 2010

This is a guest post from Cliff Cramer, Director of the Healthcare and Pharmaceutical Management Program at Columbia Business School. Do you have a response to Cramer’s post? Post them in the comments section below. Multi-national pharmaceutical and medical technology companies will increase their investments in emerging markets, notably China and India, to access cost […]


India, Intellectual Property and Biotechnology Industry

This is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so, you may respond in the comments section below. The recent editorial on “Intellectual property and biotechnology innovation: To protect or not protect” by Dr Yali Friedman, Managing Editor of the Journal of Commercial Biotechnology was […]


Pfizer's Power on Individualized Medicine

In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s genome is sequenced and drug prescriptions are based on your genetic makeup, and argues that personalized medicine will be the defining paradigm for discovering and developing drugs of the future. To put these videos into […]


Naturally Obsessed: The Making of a Scientist

Guest content from Naturally Obsessed Naturally Obsessed: The Making of a Scientist A documentary about careers in science “So what is it that you actually do, Dr. Rifkind?” (groan, groan) It didn’t matter if the question was from my accountant, my dinner party companion or my cousin Minnie, I was never able to give an […]


Koronis: Developing a new treatment for HIV

I recently had the opportunity to conduct a brief interview with Jeff Parkins, Vice President of Clinical Development and Regulatory at Koronis on his company and the future of the biotechnology industry: Can you tell me a little bit about Koronis and its mission? Koronis Pharmaceuticals develops anti-viral therapeutics based on Viral Decay Acceleration TM […]